Ambalal Sarabhai Enterprises Ltd.
| BSE: 500009 | Sector: Health care |
| NSE: AMBASARABH | ISIN Code: INE432A01017 |
| BSE 16:01 | 25 Feb | 18.80 |
-0.45 (-2.34%) |
OPEN
19.10 |
HIGH
19.55 |
LOW
18.80 |
| NSE 05:30 | 01 Jan | Ambalal Sarabhai Enterprises Ltd |
| OPEN | 19.10 |
| PREVIOUS CLOSE | 19.25 |
| VOLUME | 34008 |
| 52-Week high | 30.95 |
| 52-Week low | 12.50 |
| P/E | 10.99 |
| Mkt Cap.(Rs cr) | 144 |
| Buy Price | 19.00 |
| Buy Qty | 20.00 |
| Sell Price | 19.55 |
| Sell Qty | 700.00 |
Ambalal Sarabhai Enterprises Ltd. (AMBASARABH) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 863.15 | 1.00 | 0.12 | 13266.48 |
| Cipla | 809.10 | 19.55 | 2.48 | 12659.15 |
| Sun Pharma.Inds. | 609.70 | 7.15 | 1.19 | 12531.93 |
| Dr Reddy's Labs | 4479.25 | 37.75 | 0.85 | 11850.40 |
| Lupin | 1023.45 | 15.85 | 1.57 | 11025.66 |
| Apollo Hospitals | 3102.60 | 44.35 | 1.45 | 9794.50 |
| Glenmark Pharma. | 472.55 | 6.15 | 1.32 | 6712.63 |
| Alkem Lab | 2752.00 | -13.40 | -0.48 | 6677.08 |
| Cadila Health. | 437.50 | 3.60 | 0.83 | 6347.40 |
| Torrent Pharma. | 2464.80 | -11.55 | -0.47 | 6168.44 |
| Divi's Lab. | 3439.00 | -44.10 | -1.27 | 5310.57 |
| Ipca Labs. | 1865.50 | -2.50 | -0.13 | 4337.82 |
| Piramal Enterp. | 1958.00 | 99.20 | 5.34 | 4219.19 |
| Alembic Pharma | 897.80 | 13.10 | 1.48 | 4132.55 |
| Abbott India | 14377.75 | -204.65 | -1.40 | 4093.14 |
| Glaxosmi. Pharma | 1479.00 | 23.70 | 1.63 | 3224.68 |
| Jubilant Pharmo | 775.00 | 19.60 | 2.59 | 3139.90 |
| Sanofi India | 8141.00 | -15.30 | -0.19 | 3070.60 |
| Laurus Labs | 357.35 | -2.45 | -0.68 | 2797.34 |
| Gland Pharma | 2416.00 | 48.90 | 2.07 | 2633.24 |
Quick Links for Ambalal Sarabhai Enterprises:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
